Ad Code: 23166

Abrocitinib and upadacitinib seem to be slightly better than dupilumab for the treatment of AD, according to a study published in JAMA Dermatology. Aaron M. Drucker, MD, from the University of Toronto, and colleagues compared...

The overall risk for acne is comparable for adults with AD and controls, according to a study published in the Journal of the European Academy of Dermatology and Venereology. Jacob P. Thyssen, MD, PhD, and colleagues examined...